Exfoliative Toxins of Staphylococcus aureus by Mariutti, Ricardo B. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 8
Exfoliative Toxins of Staphylococcus aureus
Ricardo B. Mariutti, Natayme R. Tartaglia,
Núbia Seyffert, Thiago Luiz de Paula Castro,
Raghuvir K. Arni, Vasco A. Azevedo, Yves Le Loir and
Koji Nishifuji
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/66528
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Ricardo B. Mariutti, Natayme R. Tartaglia, 
Núbia Seyffert, Thiago Luiz de Paula Castro, 
Raghuvir K. Arni, V sco A. Az vedo, Yve  
Le Loir and Koji Nishifuji
Additional information is available at the end of the chapter
Abstract
Virulent strains of Staphylococcus aureus secrete exfoliative toxins (ETs) that cause the loss 
of cell‐cell adhesion in the superficial epidermis. S. aureus ETs are serine proteases, which 
exhibit exquisite substrate specificity, and their mechanisms of action are extremely com‐
plex. To date, four different serotypes of ETs have been identified and three of them (ETA, 
ETB and ETD) are associated with toxin‐mediated staphylococcal syndromes related to 
human infections leading to diseases of medical and veterinary importance.
Keywords: epidermolytic diseases, Staphylococcus aureus, exfoliative toxins, Desmoglein 1, 
keratinocytes
1. Introduction
Staphylococcus aureus, a commensal and opportunistic microorganism, is capable of colonizing 
the skin and mucous of individuals and represents a global public health problem [1–3]. It has 
been described as the etiological agent of various diseases both in humans and animals and is 
the main representative bacteria of the genus Staphylococcus [4]. S. aureus is a versatile micro‐
organism and is capable of quickly adapting to different environmental conditions [5, 6]. This 
microorganism secretes several virulence factors that are associated with its pathogenesis [2] 
and in facilitating access to sites in the host that are normally sterile [7]. Diseases caused by 
S. aureus do not necessarily originate only by direct tissue invasion, but may be due to the 
action of more than 30 exoproteins codified by the pathogen [8, 9].
The exfoliative toxins (ETs) also known as epidermolytic toxins, are serine proteases secreted 
by S. aureus that recognize and hydrolyze desmosome proteins in the skin. ETs have been 
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described as exotoxins produced by certain S. aureus strains, in the epidermis of the host, that 
have been associated with the loss of keratinocytes and with the cell‐cell adhesion, inducing 
peeling of the skin and blister formation [10–13].
In 1878, Baron Gottfried Rotter Von Rittershain described the clinical features of epidermal exfo‐
liation in newborns [14]. The relationship between skin exfoliation and S. aureus was established 
in 1967 by Lyell [14–16] and in 1972 [17] epidermal detachment at the stratum granulosum was 
established by electron microscopy. The pathogenic role of those toxins was demonstrated in 
1970 by Melish and Glasgow by using newborn mice as experimental models [18]. However, the 
protein capable of causing generalized exfoliation in mice, denominated as exfoliatin, was not 
isolated and purified until 1971 [19] and subsequently serotypes have been identified [20, 21].
The principal isoforms of exotoxins implicated in human skin damage are exfoliative toxin A 
(ETA) and exfoliative toxin B (ETB) [22]. Exfoliative toxin C (ETC) isolated from a horse infec‐
tion has not been associated with human disease. In 2002, a new exfoliative toxin (ETD) was 
identified in a clinical sample of S. aureus [13]. Recent crystallographic studies indicated that 
the ETD‐like protein isolated from ewe mastitis [23] is structurally homologous to ETA and 
ETB [24]. ETA is codified by the eta gene on chromosomal DNA, carried on the genome on a 
temperate phage, and ETB by the etb gene on a large plasmid DNA [22, 25, 26]. ETD is codified 
by the etd gene which is located chromosomally on a pathogenicity island [13].
The ETA and ETB serotypes are homologous, have molecular masses of approximately 
27 kDa, and contain 242 and 246 amino acids, respectively [22] and present identical dermato‐
logic symptoms [26, 27].The ETA serotype was described as being heat stable whereas the ETB 
serotype has been demonstrated to be heat labile. The ETC serotype with a molecular mass of 
27 kDa is also heat labile and causes exfoliation in mice and chickens [28].
2. Exfoliative toxins and associated diseases
ET‐producing strains of S. aureus are related to localized epidermal infections such as bul‐
lous impetigo and generalized diseases like Staphylococal scalded skin syndrome (SSSS). 
Approximately 5% of all S. aureus strains produce exfoliative toxins, with ETA being most 
prevalent in Europe, Africa, and America and ETB being more common in Japan [26]. Most 
strains of S. aureus associated with SSSS in Europe and the United States belong to the type 
II phage group, such as 71 and 55/71, however, in Japan; most of the strains belong to other 
groups [15, 29]. In France, based on a retrospective study conducted between 1997 and 2007 
[30], the mean incidence of SSSS cases was estimated to be 0.56 cases/year/million inhabitants.
Both ETA and ETB are distinguished by the extent of the damage caused in the epidermis 
[29, 30]. SSSS clinical manifestations involve fever, skin hypersensitivity, and erythema followed 
by superficial blister formation and skin separation, leaving long areas of denuded skin [10, 31]. 
In the localized form, toxin production and formation of flaccid blisters with purulent fluid 
occur [12, 30]. SSSS occurs mainly in newborns and children with occurrences in adults being 
rare [11, 32]. The mortality rate in children submitted to immediate treatment is low [33].
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The greater susceptibility of children has been attributed to the immature immune system, 
weak renal clearance of the toxin, and the fact that children are common carriers of microor‐
ganisms [30]. In the most severe cases, exfoliation may affect the entire corporal surface [33]. 
The quick and sensitive diagnosis of those infections may be performed using radioimmuno‐
assays, enzyme‐linked immunosorbent assays, the reverse passive latex agglutination assay 
[26] as well as the polymerase chain reaction (PCR) to amplify the genes that codify ETs.
When the ET serotypes and the clinical forms of the disease were correlated, the ETA toxin 
was found to be associated with bullous impetigo formation, whereas ETB was found to be 
associated with SSSS, a generalized manifestation [34]. The ETB plasmid has multiple genes 
that confer antibiotic resistance, which contributes to the increased resistance of etb‐positive 
S. aureus strains [35]. The etd‐positive strains have been isolated mainly from patients with 
deep pyoderma [12].
In addition to S. aureus, Staphylococcus hyicus and Staphylococcus chromogenes are also associ‐
ated with skin infections and produce exfoliative toxins [36]. In S. hyicus, ET production has 
been associated with exudative epidermitis (EE) in pigs [37]. The toxin also has the capacity 
to cleave swine desmoglein [38, 39]. Clinical manifestations are characterized by exfoliation 
accompanied by epidermal cell separation, erythema, and serous exudation [40]. The isolated 
toxins of these clinical manifestations have been denominated as SHETA and SHETB [41] 
and ExhA, ExhB, ExhC [41], and ExhD [38, 42]. In 2007, a Staphylococcus sciuri strain, highly 
pathogenic and ExhC‐positive, was described as the etiological agent of EE in pigs in China 
[43]. The ExhC recombinant protein (rExhC) has induced necrosis in vitro and has caused skin 
lesions in newborn mice [44].
Currently many phylogenetically distant hosts are described as being susceptible to exfoliation 
caused by the same isoforms of ET, revealing a certain specificity for various host organisms [29]. 
Among six different ETs (SHETA, SHETB, ExhA, ExhB, ExhC, and ExhD) codified by S. hyicus, 
SHET toxins caused exfoliation in piglets and chicks, but not in mouse, rat, guinea pig, hamster, 
dog, or cat [30]. All four Exh toxins cause exfoliation in pigs, but only ExhA and ExhC cause it in 
neonatal mice [40, 42]. SCET exfoliative toxin of Staphylococcus chromogenes also induces exfolia‐
tion in two different hosts; pigs and chicks. Different hosts are also susceptible to EXI exfoliative 
toxin of Staphylococcus pseudintermedius that induces exfoliation in dogs and mice.
Infections by et‐positive Staphylococcus intermedius in dogs can also cause a pathology that 
resembles SSSS and EE [45]. A previous study described the distribution of toxin genes 
among phage types of animal isolates of S. aureus and the canine isolates of phage group II 
that harbored the eta gene [46].
In Japan, hospital‐acquired methicillin‐resistant S. aureus (HA‐MRSA) strains frequently carry 
the etb gene [47] and, isolated samples of etb‐positive S. aureus have been encountered in 
strains with mecA, contrary to the isolated samples of eta‐positive S. aureus [48].
ET‐producing S. aureus strains (eta and etb) are related to the clonal complex CC121 [49]. 
Infections with Staphylococci of this complex are associated with clinical features like impe‐
tigo, staphylococcal scalded skin syndrome, conjunctivitis, and exfoliative dermatitis [50].
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3. Structural biology and mechanism of exfoliative toxins
The crystal structure of ETA was the first to be determined in atomic detail [51], followed by 
ETB [52] and by ETD [24] and currently, the atomic coordinates of six ET structures have been 
deposited with the Protein Data Bank (www.rcsb.org). The crystallographic structures of ETs 
have revealed much about their mechanisms of action, lack of hydrolytic activity against sub‐
strates in the native state, and the susceptibility of certain constituent layers of the epidermis 
to disruption by ETs.
4. Similarities and differences among ETs and other serino proteinases
Exfoliative toxins are glutamic‐acid specific trypsin‐like serine proteinases that share 50% 
sequence identity but display very low sequence identity with other serine proteases. The 
significant sequence identity of ETs is also reflected in the high structural similarity as evi‐
denced by the low RMSD values of the superposed structures (ETA‐ETB: 0.9, ETA‐ETD: 
1.3, and ETB‐ETD: 0.6). Similar to other trypsin‐like serine‐proteinases, the three‐dimen‐
sional structures of ETs are characterized by two six‐stranded β‐barrels domains, S1 and 
S2, whose axes lie roughly perpendicular to each other, a Greek key motif consisting of 
four antiparallel strands and N‐ and C‐terminal extensions. The amino acids constitut‐
ing the catalytic triad (His‐Ser‐Asp) and Thr190 and His213 which are characteristic of 
glutamate‐specific serine proteinases are located at the junction of the S1 and S2 domains 
[51, 53].
ETs specifically cleave both mouse and human desmoglein 1 following glutamic acid 381, 
however only the presence of the Glu381–Gly382 bond, highly conserved in desmogleins, does 
not guarantee hydrolysis. The prerequisites for the exquisite specificity exhibited by ETs 
involves not only the presence of this cleavage site, but, also (1) the presence of the highly 
charged N‐terminal alpha‐helix, (2) the calcium dependent conformation of its substrate 
Dsg‐1, and (3) existence of a specific sequence 110 residues upstream of the cleavage site of 
the substrate Dsg‐1, characteristics that differentiate them from other typical glutamic‐acid‐
specific serine proteinases of the chymotrypsin family.
(1) The highly charged N‐terminal alpha‐helix of ETs: The charge profile of N‐terminal 
alpha‐helix is significantly different, principally between ETD/ETA and ETB (Figure 1D) and 
its size also varies, containing 15, 11 and 12 residues in ETA, ETB and ETD, respectively.
This N‐terminal extension which is unique to ETs and its deletion results in an inactive 
protein [53, 54] that interacts with residues in loop 2 thereby coordinating and deter‐
mining the architecture of the S1 pocket and hence contributing to substrate specificity 
[51–53] by modifying the pocket entrance. The amino acid sequences (Figure 1D) and the 
conformations in loop2 (Figure 1E) are different in the ETs. In ETA (Figure 1E), this loop 
is longer than in ETB and ETD, additionally its Trp14 and Tyr18 present in the N‐terminal 
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helix are buried deeper in the S1 pocket than in ETB which contains Lys and Glu and 
in ETD with Arg and Lys at these equivalent positions. In the other trypsin‐like serine 
proteinases, the presence of a disulfide bridge determines the conformation of the pocket 
(Figure 1A).
(2) Calcium dependent conformation of Dsg‐1: Dsg1 is a member of the cadherin super‐
gene family [55] and most of these proteins require calcium to promote cell–cell adhesion and 
to ensure the proper conformation [56, 57]. Unlike trypsin, ETs are not capable of cleaving 
heat‐denatured Dsg1 or Ca2+ depleted Dsg1 [58] and circular dichroism demonstrates that ET 
specificity is dependent on calcium‐stabilized conformation of Dsg1.
(3) Residues upstream of the Dsg‐1 cleavage site are critical for its hydrolysis by ETA: 
ETA is able to bind but is unable to cleave canine Dsg1 and a sequence of 5 amino acids 110 
residues upstream of the cleavage site are essential for the hydrolysis of Dsg1 by ETA [59]. 
Four of five of these critical residues are identical in human and mouse Dsg‐1(Figure 2) and 
when replaced in canine Dsg‐1 at its same position, the cleavage by ETA becomes suscep‐
tible. The recognition of this peculiar sequence (Q271‐x‐x‐Y274‐T275‐I276‐E277) is one of the 
factors that make ETs highly specific in Dsg cleavage, even among homologous Dsg‐1s. This 
also demonstrated that E5 and EC4 do not exert any influence on the cleavage of the sub‐
strate and the chimeric human Dsg‐3 containing swapped amino acids 214‐398 of Dsg‐1was 
cleaved by ETA.
Figure 1. Results of superpositioning of the three‐dimensional structures: (A) ETD in green and a serine proteinase 
[PDB:2AIP] of the trypsin subfamily in pink. The loop 2 is dark blue in ETD, and the equivalent loop of serine proteinase 
is light blue. (B) ETA (blue), ETB (yellow) and ETD (green); amino acid sequences (C) and charge profile of the N‐terminal 
helices (D) and its variation in the amino acid sequences. (E) The lengths of loop 2 in ETA (blue), ETB (yellow) and ETD 
(green) and its variation in the amino acid sequences (F).
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5. Tyrosines 157 and 159 are essential for ETB activity
Based on the results of site‐directed mutagenesis, Sakurai et al. [60] concluded that the substi‐
tution of either Tyr 157 or 159 in ETB decreased exfoliative activity and the double mutation 
resulted in the complete loss of exfoliative activity and antigenicity. Interestingly, ETA does 
not possess either one of these tyrosines but contains Phe and His at these positions and in 
ETD these positions are occupied by Tyr and Thr.
6. Why are the exfoliative toxins inactive in the native states?
Gly193 is highly conserved in serine proteinases, however, in structures of ETs the pep‐
tide bond between residues 192 and 193 (chymotrypsin numbering) is flipped 180° relative 
to the other serine proteases. Pro192 in ETA and ETD and Val192 (ETB) form hydrogen 
bonds with both the amide nitrogen atoms and the hydroxyl oxygen atoms of the cata‐
lytic serine residues interrupting the charge‐relay‐network. These enzymes can only be 
functional if this bond is ruptured and the conformation is restored as in other serine 
proteinases.
Figure 2. Results of superpositioning of the structural model of human Dsg1(orange), canine Dsg1 (green) and mouse 
Dsg1 (blue), purple spheres represent bound Ca2+, the susceptible glutamic acid is indicated by an arrow; amino acids 
sequence of the human, mouse, and canine Dsg1s upstream of the cleavage site; upstream location of the recognition 
sequence and the susceptible glutamic acid.
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7. Molecular mechanisms of the S. aureus exfoliative toxin
7.1. S. aureus exfoliative toxins selectively and directly solubilize mouse  
and human desmoglein 1
In 1970, Melish and Glasgow first investigated mechanisms of action of the exfoliative toxin 
(ET)‐producing S. aureus in SSSS [11]. When the organisms isolated from SSSS patients 
were injected into neonatal mice, they cause epidermal blisters resembling those in the 
naturally occurred human disease. Several years later, two serotypes of ETs, ETA and ETB, 
which are capable of inducing epidermal blisters, were identified [21]. However, the exact 
molecular mechanisms of ET‐causing epidermal blisters had long been unknown over the 
three decades.
In 2000, Amagai and colleagues established desmoglein 1 (Dsg1), a desmosomal cadherin‐
type adhesion molecule and also known as pemphigus foliaceus autoantigen, as the target 
of S. aureus ETs [61]. They advocate this hypothesis based on the fact that histopathology 
of superficial epidermal blisters created by ET injection in mice resembles to those cre‐
ated by pemphigus foliaceus IgG. They revealed that immunostaining for the extracellular 
domain of Dsg1, but not that for Dsg3, is abolished in ETA‐injected mouse skin. Moreover, 
an in vitro analysis revealed that ETA selectively solubilize the recombinant extracellular 
segments of human and mouse Dsg1 (α) produced by baculovirus. The same group also 
identified that S. aureus ETB and a newly identified ETD have similar enzymatic activity to 
solubilize Dsg1 [10, 12].
The site of blister formation by ETs could be explained in the context of tissue distribution of 
desmosomal cadherins (Figure 3) [13, 62].
Figure 3. Distribution of functional tight junction and desmosomalcadherins in the epidermis. Dsg, desmoglein; 
Dsc, desmocollin. Functional tight junctions are located in the upper granular layer. Expression pattern of four 
isoforms of desmogleins (Dsg) and three isoforms of desmocollins (Dsc) is associated with differentiation level of 
keratinocytes.
Exfoliative Toxins of Staphylococcus aureus
http://dx.doi.org/10.5772/66528
133
In humans, there are four subclasses of Dsg with different tissue distributions. Among them, 
Dsg2 is expressed in all desmosome‐bearing tissues, whereas Dsg1 and Dsg3 are expressed 
preferentially in stratified squamous epithelia [63]. Dsg1 and Dsg3 are hypothesized to have 
compensatory effects [64]. For example, if both Dsg1 and Dsg3 express in the same epithelial 
cells, and adhesive function by Dsg1 is abolished, the loss of adhesive function can be com‐
pensated by intact Dsg3. In the epidermis, Dsg1 is expressed in the whole layers, whereas 
Dsg3 is expressed in basal and immediate suprabasal layers [65]. In contrast, in oral mucous 
membrane, both Dsg1 and Dsg3 are expressed in the whole layer, but the expression level 
of Dsg1 is relatively low compared with that of Dsg3 [63]. As Dsg2 and Dsg4 are expressed 
weakly in basal and upper granular layers, respectively [65], these molecules may have less 
ability to compensate the loss of Dsg1 function.
Desmocollin (Dsc) 1, another desmosomal cadherin is also expressed in superficial epidermis. 
It is hypothesized that Dsg1 and Dsc1 may have combinational effect on integrity of keratino‐
cyte cell adhesion [66]: Abolishment of either Dsg1 by ETs or genetic ablation of Dsc1 causes 
dissociation of keratinocytes in the superficial layer of mouse epidermis [10, 13, 59, 67]. If 
adhesive function of Dsg1 is abolished by ETs, it may cause keratinocyte separation only in 
spinous‐to‐granular layers of epidermis, in which loss of adhesive function by Dsg1 could not 
be compensated by other Dsgs. This could be a reasonable explanation why ETs cause only 
superficial epidermal blisters in SSSS patients, although ETs produced in upper respiratory 
organs (e.g., tonsils), enter the circulatory system and induce toxemia [27].
7.2. S. aureus ETs are unique glutamate‐specific serine proteases that hydrolyze a single 
peptide bond within the extracellular segment of Dsg1
Hanakawa et al. demonstrated that substitution of catalytic serine in ETA, ETB and ETD to ala‐
nine causes loss of their functions to solubilize Dsg1 [59]. Kinetic analysis of three ETs revealed 
kcat/Km values in the range of 2–6 × 104 M‐1 s‐1, suggesting their efficient enzymatic activity to 
digest relatively large molecules. These findings indicate that three known S. aureus ETs are ser‐
ine proteases that efficiently solubilize the extracellular segment of Dsg1.
The same group also investigated substrate‐specificity of S. aureus ETs [58]. All three ETs 
cleave human and mouse Dsg1 (α) into two segments. Moreover, mouse has three isoforms 
of Dsg1 (Dsg1‐α, ‐β and ‐γ) [65, 68], and ETA solubilize the extracellular segments of mouse 
Dsg1‐α and ‐β, but not that of Dsg1‐γ in which glutamic acid residue 381 is substituted by 
lysine [66, 68]. These findings indicate the specificity of the glutamic acid residue as the cleav‐
age site of Dsg1 by ET.
S. aureus ETs are unique serine proteases that specifically and efficiently cleave only one 
 peptide bond in the extracellular segment of Dsg1. The enzymatic properties of S. aureus ETs 
cause efficient and specific abolishment of a major epidermal adhesion molecule in selected 
mammalian species.
7.3. Possible mechanisms of ET‐associated keratinocyte dissociation
Desmosomes composed of two major transmembrane cadherin‐type adhesion molecules 
(Dsg and Dsc) and cytoplasmic plaque proteins that link between desmosomal cadherins and 
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intracellular cytoskeletons. It has been long debated questions whether disruption of Dsgs 
alone by pemphigus autoantibodies is sufficient to cause keratinocyte dissociation, or subse‐
quent disorganization of other desmosomal consituents in plasma membrane of keratinocytes 
is necessary [69].
To determine whether cleavage of the extracellular segment of Dsg1 by S. aureus ETs is suf‐
ficient to cause keratinocyte dissociation, our group has investigated the fate of desmosomal 
constituents in ETA‐injected mouse skin [66]. We found that the amino‐termini of Dsg1 is 
abolished in plasma membrane of murine epidermal keratinocytes, whereas cleaved car‐
boxyl‐termini of Dsg1 and the extracellular segment of Dsc1 remained on the surface of kera‐
tinocytes faced to blister cavity in the early phase of keratinocyte dissociation. Based on these 
findings, we proposed a theory that removal of the amino‐termini of Dsg1 by ETs is sufficient 
to initiate in vivo keratinocyte dissociation.
Meanwhile, Simpson et al. proposed another theory for ET‐induced keratinocyte dissocia‐
tion through sequestration of plakoglobin (PG), a member of catenin family cytoplasmic pro‐
tein, by ectodomain‐deleted Dsg1 [70]. When truncated Dsg1, in which amino acids 1–381 
were spliced to mimic ET‐cleaved carboxy‐termini of Dsg1, was expressed in primary human 
keratinocytes, it reduced mechanical strength of keratinocyte sheets in a dose‐dependent 
manner, implicating a dominant‐negative effect by truncated Dsg1. Truncated Dsg1 local‐
ized in close to intercellular borders and reduce endogenous desmosomal cadherin Dsc3 and 
desmosomal plaque protein desmoplakin in intercellular borders. In the same cells, PG local‐
ized in intercellular borders and seem to be associated with truncated Dsg1. Remarkably, 
triple‐point mutation of the PG‐binding region in the truncated Dsg1 restored mechanical 
integrity of keratinocyte sheets, implicating that PG binding to truncated Dsg1 is essential in 
disruption of desmosomes and subsequent keratinocyte dissociation.
Putting all these findings together, the authors advocate a theory that cleavage of Dsg1 by ETs ini‐
tiate keratinocyte dissociation, while subsequent PG sequestration may contribute to the expan‐
sion of intercellular spaces between keratinocytes (Figure 4). Further accumulation of in vivo 
evidences to elucidate the role of PG in ET‐inducing keratinocyte dissociation will be expected.
7.4. How ET‐producing S. aureus penetrate the epidermis through firm keratinocyte 
adhesion in the upper stratum granulosum?
The aforementioned theory can satisfactorily explain how ETs cause blistering in SSSS, in 
which ETs access to the skin from dermal side. However, this theory cannot explain the mech‐
anisms of blistering in bullous impetigo, in which ET‐producing S. aureus enter the epidermis 
from the skin surface. It has been reported that ETs do not penetrate tight junction, an occlu‐
sive adhesive structure located at the upper granular layer (Figure 5) [71]. Then the question 
arises how ET‐producing S. aureus invade the epidermis apart from a route of microwounds 
on the skin.
To address this issue, we recently established a mouse model of bullous impetigo [72]. S. 
aureus harboring etb gene was inoculated epicutaneously to murine inner pinnae after the 
stratum corneum was partially removed by tape stripping. Intraepidermal neutrophilic pus‐
tules containing intercellular staphylococci were successfully created in the mouse skin by 6 
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Figure 4. Possible mechanisms of ET‐induced keratinocyte dissociation. PG, plakoglobin. Cleavage of the extracellular 
segment of Dsg1 initiates keratinocyte separation. Sequestration of PG by truncated Dsg1 and disintegrity of other 
desmosomal components are associated with expansion of the intercellular spaces between keratinocytes.
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hours after the inoculation. The size of intraepidermal pustules created by etb gene‐harboring 
strains was significantly larger than those created by et gene‐negative strains. Chronological 
study revealed that staphylococci invaded the epidermis after neutrophils infiltrated the skin. 
Moreover, if the neutrophilic infiltration was blocked by injection of cyclophosphamide, 
staphylococci in the epidermis were not recognized at all.
Based on these findings, we propose a novel hypothesis for percutaneous entry of ET‐produc‐
ing S. aureus in bullous impetigo. These strains may invade the epidermis through intercel‐
lular spaces created by skin‐infiltrated neutrophils. In addition, once S. aureus invade the 
epidermis, ETs expand the interkeratinocyte spaces, which allows bacteria to skew neutro‐
phils attack in blister cavity. Future studies to elucidate the molecular interactions that under‐
lie neutrophilic epidermal infiltration in response to S. aureus adhere to living keratinocytes. 
In addition, the mechanisms how ET‐producing penetrate the stratum corneum remains to 
be elucidated.
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Figure 5. Proposed theory for bacterial cutaneous invasion and blistering in bullous impetigo. S. aureus harboring at 
gene adhere to the living epidermis recruits neutrophils. When neutrophils create intercellular gap between superficial 
keratinocytes, S. aureus produce ET to expand the blisters by cleavage of Dsg1.
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